Introduction
Seasonal influenza epidemics caused by influenza A and B viruses occur annually during the winter in temperate regions, with an annual attack rate estimated at 5-10% in adults and 20-30% in children. 1, 2 Worldwide, these annual epidemics are estimated to result in 3-5 million cases of severe illness, and about 250 000 to 500 000 deaths. 1, 2 Influenza epidemics can impose a considerable economic burden in the form of hospital and other healthcare costs and lost productivity. [1] [2] [3] This recurrent distinctive epidemiological feature rests on the high propensity of influenza viruses to change the genetic and antigenic characteristics of their surface antigens hemagglutinin (HA) and neuraminidase (NA)-the main targets for the human immune system. 4 Control and prevention of influenza rely on the international cooperation of a wide range of public health partners brought together under the coordination of the World Health Organization (WHO) in the Global Influenza Surveillance and Response System (GISRS). 5 The overarching goal of the WHO GISRS is to minimise the impact of the disease by providing information to public health authorities for planning appropriate control and intervention measures and health resource allocation. The specific goal is to provide timely, high-quality data to evaluate the impact and severity of each season, to determine the influenza burden, to monitor the evolution of influenza viruses, and to provide recommendations in areas including laboratory diagnostics, vaccines, antiviral susceptibility and risk assessment. The WHO GISRS also serves as a global alert mechanism for the emergence of influenza viruses with pandemic potential. 5 Altogether, the surveillance activities performed by this network as the regional influenza reference centre operating within the Italian network InfluNet, here we report data on virological and epidemiological surveillance of influenza, as well as on the vaccination coverage rates achieved in Lombardy (Northern Italy) over 10 consecutive winter seasons (2004) (2005) (2006) (2007) (2008) (2009) (2010) (2011) (2012) (2013) (2014) .
Over the past 10 years, influenza vaccine coverage declined both in the general population (from 15. The continuous surveillance of the characteristics of circulating viruses is an essential tool for monitoring their matching with seasonal vaccine strains. strategies to increase coverage rates are warranted.
are crucial to make the annual update of vaccine composition a reliable option, rather than a risky bet, to use for the control and prevention of influenza at a global level.
As part of the Italian influenza surveillance network, the activity and circulation of influenza viruses in Northern Italy (specifically, Lombardy, which is the most populous Italian region and which accounts for nearly 10 million of the 60 million inhabitants of Italy) were investigated during 10 consecutive winter seasons (from 2004-2005 to 2013-2014). The aim of this paper is to describe data on epidemiological and virological surveillance of influenza, as well as the influenza vaccine coverage rates in Northern Italy over the last 10 influenza seasons.
Results

Epidemiological surveillance
In the surveyed area, the epidemic waves had different epidemiological profiles over the last 10 consecutive influenza seasons. Table 1 shows the incidence of ILI at its peak during the considered influenza epidemics in the general population and by age group. In the general population, the highest ILI morbidity rates The weeks during which peak incidence was reported are in brackets.
nearly 8‰) and time frame (peak at week 5). These three seasons were characterised by the alternation of predominant viral type/ subtype: A(H1N1)pdm09 virus in 2010-2011, A(H3N2) virus in 2011-2012, and influenza B virus in 2012-2013. The latter influenza season considered (2013-2014) was characterised by a lower influenza activity compared with the eight previous ones, with a peak ILI morbidity below 5‰. In all considered seasons, the highest ILI incidence rates were recorded in children ≤4-y-of-age and in school-aged children (5-14 y). Children ≤4-y-of-age were usually affected more during the epidemics sustained by the A (H3N2) -2012 seasons, the ILI morbidity rates in the population over 65-y-of-age were higher than those registered in the other epidemics (including the pandemic one). Both of these seasons were characterised by the predominant circulation of A(H3N2) viruses with specific antigenic and genetic features. 6, 7 Virological surveillance Respiratory samples (nasal swabs) were collected from outpatients with a clinical presentation of ILI. Overall, 5952 nasal swabs were collected and analysed during the study period. The percentage of samples that resulted in positive influenza virus identification ranged between 31.8% and 46.8%. As shown in Table 2 The risk of infection from any influenza virus by age group and by season was calculated as the number of laboratory-confirmed influenza infections out of the total number of subjects with ILI. As shown in Figure 1 , the risk of infection was always relevant among the younger subjects (0-14 y), but increased in the last seasons even among the elderly, probably as a consequence of the decrease of influenza vaccine coverage rate in this age group.
Molecular characteristics of circulating influenza viruses and match with vaccine strains
A spatial-temporal representative number of influenza-positive specimens collected during the analysed seasons was genetically characterised, and the phylogenetic analysis of the HA gene was performed. Fig. 2A) .
Influenza A(H1N1) viruses
In post-pandemic A(H1N1)pdm09 viruses remain closely related to the reference vaccine viral strain (A/California/7/2009) ( Fig. 2A) . (Fig. 2B) .
Influenza A(H3N2) viruses
Influenza B viruses
In the surveyed area, influenza virus type B detections predominated over type A only during two epidemics (i.e., 2007-2008 and 2012-2013) . In the other seasons, the proportion of influenza B virus identified ranged between 6% to 38% of all influenza virus detections. During seasons in which co-circulation of influenza A and B viruses was observed, B viruses usually circulated later in the season (end of March) than influenza A viruses (which generally circulate in January-February).
The phylogenetic analysis of the HA sequences of influenza B viruses clearly showed that B viruses presented with a mixed circulation of viral variants, since viruses belonging to both B/ Victoria and B/Yamagata lineages co-circulated in different proportions (Fig. 2C) (Fig. 3) . This decrease in coverage is likely due to a loss of confidence in the influenza vaccine after the 2009 pandemic. These coverage rates are far below the minimum planned threshold level of 75%. Each influenza season was characterised by a specific virological profile; influenza virus type A detections predominated over type B in all considered epidemics except those that occurred in 2007-2008 and in 2012-2013 . Within type A, the H3 subtype predominated over H1 in five out of the eight influenza A seasons. However, although a predominant influenza virus was identified in each season, every epidemic was characterised by composite epidemiological patterns where several viral types/subtypes circulated to a different extent.
From an epidemiological point of view, all considered influenza seasons were characterised by higher morbidity rates in children (≤14-y-of-age), whereas the lowest ILI morbidity rates were usually reported in individuals ≥65 y. This latter figure was observed in all seasons except the 2004-2005 and 2011-2012 seasons, when higher morbidity rates were reported among the elderly. It is interesting to note that both of these latter seasons were characterised by the predominant circulation of A(H3N2) viruses with specific antigenic and genetic features. 6, 7 The vaccine coverage rate among the elderly reached its peak (65.3%) in 2004-2005 and decreased consistently from 2010. This decrease is likely due to a loss of confidence in the influenza vaccine after the 2009 pandemic. 10 The molecular characterisation of circulating influenza viruses showed a general good match between seasonal vaccine strains and circulating influenza A viruses over the past 10 y. A different epidemiological profile was observed for influenza B viruses. Such viruses presented with a mixed circulation of viral variants, since viruses belonging to both B/Victoria and B/ Yamagata lineages co-circulated during the considered seasons in different proportions. As previously reported by other authors, [11] [12] [13] this epidemiological feature suggests that the inclusion of strains belonging to both B lineages in influenza vaccines may be advisable. Licensed trivalent influenza vaccines (TIV) contain antigens from only a single influenza B virus, thus providing limited immunity against circulating influenza B strains of the lineage not present in the vaccine. In recent years, predictions about which B lineage will predominate in an upcoming influenza season have been no better than casual-correct in only 5 of the 10 seasons from 2001 to 2011.
14 Seasonal influenza vaccines may be improved by inclusion of influenza B strains of both lineages. The resulting quadrivalent influenza vaccines (QIV) would allow influenza vaccination campaigns to respond more effectively to current global influenza epidemiology. 15, 16 The WHO GISRS has recommended and encouraged further research and clinical evaluation of QIV. 17 In conclusion, epidemiological and virological surveillance of influenza is an essential informative tool for tuning vaccination strategies. The continuous surveillance of the characteristics of circulating viruses is crucial to monitor their matching with seasonal vaccine strains.
Strategies to increase vaccination coverage are warranted to control and prevent influenza in individuals at risk of complications, such as the elderly, as well as in the population at large.
Materials and Methods
The Influenza Surveillance Network methodology The influenza epidemiological and virological surveillance network (InfluNet) 18 consists of a number of paediatricians and general practitioners, who survey approximately 2% of the general population, reporting weekly on the number of new cases of influenza-like illness (ILI), and collecting respiratory samples for virological evaluation. 9 The standard case definition of ILI is abrupt onset of fever (>38 °C), one or more respiratory symptoms (non-productive cough, sore throat, or rhinitis), and one or more systemic symptoms (myalgia, headache, or severe malaise). 9 Epidemiological data are collected from week 42 to week 17 of the following year, while virological surveillance begins on week 46 and ends on week 17 of the following year. Epidemiological and virological data are collected at a regional level and are aggregated subsequently at a national level on a weekly basis.
9,18
Influenza viruses identification and molecular characterisation RNA was extracted from respiratory samples using the Invisorb ® Spin Virus RNA Mini kit (Stratec Molecular GmbH, catalogue number: 1040300300). A one-step real-time retrotranscription (RT) multiplex polymerase chain reaction (PCR) assay was performed to simultaneously detect influenza A and B viruses using primer/probe sets for two different genome regions: the matrix region of influenza type A virus and the nucleoprotein region of influenza type B virus. 19 The subtyping of influenza A positive samples was performed by a one-step real-time RT-PCR assay using specific primer/probe sets for the HA gene. 19 The molecular characterisation of influenza viruses was performed by sequence analysis of the globular head region of the HA protein (HA1 subunit) specific for A(H1N1) influenza virus (nucleotide, nt., 64-1058), A(H3N2) influenza virus (nt. 174-1056), and B (nt. 12-1169) influenza virus. 11, 20, 21 The HA nucleotide sequences were obtained by automated DNA sequencing (ABI PRISM ® 3100 Genetic Analyzer, Life Technologies). Multiple sequence alignment was conducted using ClustalX, version 2.0.10.
Influenza vaccine coverage Influenza vaccine coverage rates are presented as the percentage of individuals immunised with influenza vaccine per year. The record of the number of individuals vaccinated in Lombardy was collected from local health authorities and then put in the data warehouse managed and coordinated by the Directorate General for Health, Regione Lombardia. To estimate vaccine coverage rates, data on population were obtained from the Italian National Institute of Statistics (Istat) database.
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Statistical analysis
The risk of infection is expressed as number of subjects with a laboratory-confirmed infection out of the total number of subjects with ILI. Data were analysed by the Open Source Epidemiologic Statistics for Public Health (OpenEpi), version 3.01.
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